Skip to main content
All lobbying filings

CORMEDIX INC.

Lobbying for CORMEDIX INC. · Biopharmaceutical company.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $150,000.00 expenses · posted Feb 5, 2026

Official filing document

 Bills named in this filing 4
  • HR 2172
    Preserving Patient Access to Home Infusion Act
  • S 1058
    Preserving Patient Access to Home Infusion Act
  • HR 6214
    Kidney Care Access Protection Act
  • S 2730
    Kidney Care Access Protection Act
 Lobbying activity 1
Health Issues

H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem